Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matjaz, Vrtovec"'
Publikováno v:
Radiology and oncology (Ljubljana)
Radiology and Oncology, Vol 51, Iss 2, Pp 203-210 (2017)
Radiology and Oncology
Radiology and Oncology, Vol 51, Iss 2, Pp 203-210 (2017)
Radiology and Oncology
Background Patients with myeloproliferative neoplasms (MPNs) are at increased risk for atherothrombotic events. Our aim was to determine if patients with essential thrombocytosis (ET), a subtype of MPNs, free of symptomatic atherosclerosis, have grea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7198fa5b2f01f1c2084bdbea91dafbcf
http://www.dlib.si/details/URN:NBN:SI:doc-M9WC65R5
http://www.dlib.si/details/URN:NBN:SI:doc-M9WC65R5
Publikováno v:
Blood. 132:2417-2417
INTRODUCTION Essential thrombocythemia (ET) is a classic Philadelphia chromosome-negative myeloproliferative neoplasm with low progression rate to secondary myelofibrosis and transformation to acute leukemia. Patient survival is prolonged and the mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea6f4c976b05668b63a0c675585780a1
https://doi.org/10.1182/blood-2018-99-111862
https://doi.org/10.1182/blood-2018-99-111862
Autor:
Bojan Vrtovec, Alenka Sešek Briški, Andreja Kocijancic, Richard Anderson, Matjaz Vrtovec, Branislav Radovancevic
Publikováno v:
American heart journal. 149(4)
Background We investigated the potential effects of chromium supplementation on QTc interval duration in type 2 diabetic patients. Methods Of 60 patients with type 2 diabetes mellitus, 30 were randomly assigned to group A, and 30 to group B. Group A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1b7e4ab3597f2c6d8e17c035a629b2
https://pubmed.ncbi.nlm.nih.gov/15990745
https://pubmed.ncbi.nlm.nih.gov/15990745
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 11(12)
Postprandial hyperglycemia contributes to glycation of hemoglobin A1c and has been associated with cardiovascular risk in people with diabetes. We investigated the impact of injection timing of Humalog Mix25 (Mix25, known as Humalog Mix75/25 in the U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a89f0aac2a62e1641569a0198b571aa
https://pubmed.ncbi.nlm.nih.gov/16319804
https://pubmed.ncbi.nlm.nih.gov/16319804
Publikováno v:
Diabetes Research and Clinical Practice. 50:37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83be1f57a98e3793ee25cb9af810b1b4
https://doi.org/10.1016/s0168-8227(00)81584-3
https://doi.org/10.1016/s0168-8227(00)81584-3
Publikováno v:
Journal of the American College of Cardiology. (5):A510
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205363a2076224b0708944173970192b